Skip to main content

Table 1 Patients’ baseline characteristics

From: The rate of ward to intensive care transfer and its predictors among hospitalized COPD patients, a retrospective study in a local tertiary center in Saudi Arabia

Variable

Frequency

Percentage

Gender

Males

425

60.3%

Mean age (Standard deviation (SD)) years

65.4 (25.3) years

Mean Body Mass Index (BMI) (Standard deviation (SD)) kg/cm2

29.2 (6.8) kg/cm2

Smoking status

Non-smoker

182

25.8%

Ex-smoker

258

36.5%

Current smoker

265

37.5%

Long-Term Home Care Service

Yes

55

7.8%

Mean FEV1

62.9 (17.3)

Mean FEV1/FVC ratio

57.5 (10.3)

Comorbidities

Diabetes mellitus

288

40.9%

Hypertension

287

40.7%

Gastroesophageal diseases (GERD)

186

26.4%

Ischemic heart disease

135

19.1%

OSAS

92

13.0%

Heart failure

65

9.2%

Chronic kidney disease

40

5.7%

Stroke

38

5.4%

Connective tissue diseases

23

3.3%

Tumour or malignancy

21

2.9%

Hemiplegia

16

2.3%

Peripheral vascular diseases

11

1.6%

Dementia

9

1.3%

Liver disease

4

0.6%

AIDS/HIV

2

0.3%

Rheumatological disease

1

0.1%

Hospital admission due to COPD in the past two years

Yes

263

37.3%

Number of hospital admissions in the past two years

Zero

442

62.8%

1

147

20.9%

2

70

9.9%

3

21

3.0%

4

10

1.4%

5

8

1.1%

6

4

0.6%

7

2

0.3%

ICU hospital admission due to COPD in the past two years

Yes

84

12.4%

Number of ICU admissions in the past two years (n = 702)

Zero

615

87.6%

1

66

9.4%

2

16

2.3%

3

4

0.6%

4

1

0.1%

Long-term non-COPD Medications

Antihypertensive

288

40.9%

Oral antidiabetic agents or insulin

279

39.6%

Proton pump inhibitors

190

27.0%

Anti-dyslipidemic

182

25.9%

Antiplatelets

151

21.4%

CHF medications

76

10.8%

Antipsychotic and antidepressants

54

7.7%

Osteoporosis drugs

51

7.2%

Anticoagulants

45

6.4%

Proton pump inhibitors (PPI) and Anti-histamine (H2 blockers)

8

1.1%